US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals

Watchlist

17.860
+0.180+1.02%

Close Apr 24 16:00 ET

17.450
-0.410-2.30%

Post 18:53 ET

1.27BMarket Cap137.38P/E (TTM)

Kiniksa Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

129.05%13.3M

137.36%4.33M

-72.63%16.99M

52.16%-3.74M

88.42%-4.27M

104.60%5.81M

38.70%-11.58M

317.66%62.05M

79.83%-7.82M

8.17%-36.85M

Net income from continuing operations

-92.32%14.08M

465.73%25.24M

-106.18%-13.86M

174.93%14.97M

51.33%-12.27M

216.11%183.36M

112.28%4.46M

833.67%224.09M

51.93%-19.98M

49.05%-25.21M

Operating gains losses

442.42%179K

-60.00%4K

--0

--175K

-67.96%33K

--10K

---11K

----

Depreciation and amortization

-2.54%2.34M

-10.30%540K

22.31%603K

-7.53%602K

-9.15%596K

2.00%2.4M

-9.88%602K

-25.08%493K

-9.21%651K

110.26%656K

Deferred tax

81.78%-33.79M

-7,487.64%-25.71M

105.54%10.29M

---19.44M

--1.08M

-1,686,418.18%-185.5M

3,063.64%348K

---185.84M

--0

Other non cash items

0.43%3.05M

-6.47%737K

-8.42%707K

3.08%769K

14.42%841K

15.58%3.04M

7.07%788K

9.97%772K

24.33%746K

23.95%735K

Change In working capital

105.98%1.35M

83.46%-3.96M

-33.76%11.01M

-250.05%-5.96M

101.35%260K

-3,376.49%-22.58M

-345.61%-23.95M

400.23%16.63M

189.57%3.97M

-2,209.99%-19.22M

-Change in receivables

94.18%-950K

-99.03%-18.23M

744.85%21.61M

-179.63%-17.23M

150.65%12.89M

-317.67%-16.33M

-1,234.84%-9.16M

-397.92%-3.35M

947.98%21.63M

---25.46M

-Change in inventory

46.87%-9.52M

20.62%-5.54M

-130.69%-1.63M

92.04%-533K

80.88%-1.83M

-387.73%-17.92M

-461.37%-6.98M

583.23%5.3M

-4.89%-6.69M

---9.55M

-Change in prepaid assets

-83.18%-7.07M

81.70%8.85M

-971.80%-13.99M

120.32%709K

33.01%-2.63M

-231.18%-3.86M

155.27%4.87M

-206.10%-1.31M

-477.65%-3.49M

-1,063.73%-3.93M

-Change in payables and accrued expense

644.49%17.29M

374.42%12.52M

768.41%7.97M

304.10%13.95M

-406.34%-17.16M

-80.16%2.32M

-74.36%2.64M

118.37%918K

-230.04%-6.84M

386.53%5.6M

-Change in other current assets

72.72%4.58M

630.57%1.41M

--0

-155.21%-90K

18.62%3.27M

180.82%2.65M

88.09%-265K

100.13%1K

439.58%163K

1,292.64%2.76M

-Change in other current liabilities

-125.45%-3.24M

-2.85%-793K

-191.27%-711K

1.12%-795K

-46.88%-943K

53.43%-1.44M

47.48%-771K

171.21%779K

-637.61%-804K

-53.96%-642K

-Change in other working capital

-97.83%261K

84.78%-2.18M

-115.70%-2.24M

---1.98M

-44.52%6.66M

--12M

---14.29M

--14.29M

--0

--12M

Cash from discontinued investing activities

Operating cash flow

129.05%13.3M

137.36%4.33M

-72.63%16.99M

52.16%-3.74M

88.42%-4.27M

104.60%5.81M

38.70%-11.58M

317.66%62.05M

79.83%-7.82M

8.17%-36.85M

Investing cash flow

Cash flow from continuing investing activities

-265.90%-29.56M

65.09%-14.89M

-164.48%-12.28M

-7.14%35.53M

-66.88%-37.92M

-106.28%-8.08M

14.75%-42.66M

-60.21%19.04M

-55.50%38.27M

-150.68%-22.72M

Net PPE purchase and sale

-828.57%-130K

-233.33%-56K

50.00%-16K

-41.67%-34K

---24K

96.63%-14K

116.73%42K

37.25%-32K

59.32%-24K

--0

Net intangibles purchase and sale

--0

----

--0

----

Net investment purchase and sale

-264.92%-29.43M

65.25%-14.84M

-164.29%-12.26M

-7.11%35.57M

-66.77%-37.9M

-105.41%-8.06M

14.24%-42.7M

-60.18%19.07M

-55.50%38.29M

-135.02%-22.72M

Cash from discontinued investing activities

Investing cash flow

-265.90%-29.56M

65.09%-14.89M

-164.48%-12.28M

-7.14%35.53M

-66.88%-37.92M

-106.28%-8.08M

14.75%-42.66M

-60.21%19.04M

-55.50%38.27M

-150.68%-22.72M

Financing cash flow

Cash flow from continuing financing activities

-40.58%1.5M

-41.60%695K

52.91%552K

-70.85%158K

-78.72%90K

-57.25%2.52M

-1.82%1.19M

-86.53%361K

-38.90%542K

-61.75%423K

Net common stock issuance

-144.84%-2.21M

-162.00%-262K

-431.25%-1.11M

-1,645.83%-419K

26.19%-420K

---901K

97.86%-100K

-104.45%-208K

---24K

---569K

Proceeds from stock option exercised by employees

8.31%3.7M

-25.81%957K

191.21%1.66M

1.94%577K

-48.59%510K

-41.94%3.42M

--1.29M

--569K

-36.19%566K

-10.31%992K

Cash from discontinued financing activities

Financing cash flow

-40.58%1.5M

-41.60%695K

52.91%552K

-70.85%158K

-78.72%90K

-57.25%2.52M

-1.82%1.19M

-86.53%361K

-38.90%542K

-61.75%423K

Net cash flow

Beginning cash position

0.20%122.72M

-32.96%117.83M

19.36%112.57M

27.31%80.62M

0.20%122.72M

7.20%122.47M

-7.58%175.76M

-43.92%94.31M

-47.26%63.32M

7.20%122.47M

Current changes in cash

-6,124.90%-14.76M

81.39%-9.87M

-93.54%5.26M

3.12%31.95M

28.83%-42.1M

-97.02%245K

21.66%-53.05M

269.91%81.45M

-35.58%30.98M

-1,116.60%-59.15M

End cash Position

-12.03%107.95M

-32.96%117.83M

19.36%112.57M

27.31%80.62M

0.20%122.72M

-7.58%175.76M

-43.92%94.31M

-47.26%63.32M

Free cash flow

130.99%13.17M

136.98%4.27M

-72.64%16.97M

52.42%-3.78M

88.35%-4.29M

103.89%5.7M

39.67%-11.54M

317.20%62.03M

79.56%-7.94M

38.77%-36.85M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	129.05%13.3M	137.36%4.33M	-72.63%16.99M	52.16%-3.74M	88.42%-4.27M	104.60%5.81M	38.70%-11.58M	317.66%62.05M	79.83%-7.82M	8.17%-36.85M
Net income from continuing operations	-92.32%14.08M	465.73%25.24M	-106.18%-13.86M	174.93%14.97M	51.33%-12.27M	216.11%183.36M	112.28%4.46M	833.67%224.09M	51.93%-19.98M	49.05%-25.21M
Operating gains losses	442.42%179K	-60.00%4K	--0	--0	--175K	-67.96%33K	--10K	---11K	----	----
Depreciation and amortization	-2.54%2.34M	-10.30%540K	22.31%603K	-7.53%602K	-9.15%596K	2.00%2.4M	-9.88%602K	-25.08%493K	-9.21%651K	110.26%656K
Deferred tax	81.78%-33.79M	-7,487.64%-25.71M	105.54%10.29M	---19.44M	--1.08M	-1,686,418.18%-185.5M	3,063.64%348K	---185.84M	--0	--0
Other non cash items	0.43%3.05M	-6.47%737K	-8.42%707K	3.08%769K	14.42%841K	15.58%3.04M	7.07%788K	9.97%772K	24.33%746K	23.95%735K
Change In working capital	105.98%1.35M	83.46%-3.96M	-33.76%11.01M	-250.05%-5.96M	101.35%260K	-3,376.49%-22.58M	-345.61%-23.95M	400.23%16.63M	189.57%3.97M	-2,209.99%-19.22M
-Change in receivables	94.18%-950K	-99.03%-18.23M	744.85%21.61M	-179.63%-17.23M	150.65%12.89M	-317.67%-16.33M	-1,234.84%-9.16M	-397.92%-3.35M	947.98%21.63M	---25.46M
-Change in inventory	46.87%-9.52M	20.62%-5.54M	-130.69%-1.63M	92.04%-533K	80.88%-1.83M	-387.73%-17.92M	-461.37%-6.98M	583.23%5.3M	-4.89%-6.69M	---9.55M
-Change in prepaid assets	-83.18%-7.07M	81.70%8.85M	-971.80%-13.99M	120.32%709K	33.01%-2.63M	-231.18%-3.86M	155.27%4.87M	-206.10%-1.31M	-477.65%-3.49M	-1,063.73%-3.93M
-Change in payables and accrued expense	644.49%17.29M	374.42%12.52M	768.41%7.97M	304.10%13.95M	-406.34%-17.16M	-80.16%2.32M	-74.36%2.64M	118.37%918K	-230.04%-6.84M	386.53%5.6M
-Change in other current assets	72.72%4.58M	630.57%1.41M	--0	-155.21%-90K	18.62%3.27M	180.82%2.65M	88.09%-265K	100.13%1K	439.58%163K	1,292.64%2.76M
-Change in other current liabilities	-125.45%-3.24M	-2.85%-793K	-191.27%-711K	1.12%-795K	-46.88%-943K	53.43%-1.44M	47.48%-771K	171.21%779K	-637.61%-804K	-53.96%-642K
-Change in other working capital	-97.83%261K	84.78%-2.18M	-115.70%-2.24M	---1.98M	-44.52%6.66M	--12M	---14.29M	--14.29M	--0	--12M
Cash from discontinued investing activities
Operating cash flow	129.05%13.3M	137.36%4.33M	-72.63%16.99M	52.16%-3.74M	88.42%-4.27M	104.60%5.81M	38.70%-11.58M	317.66%62.05M	79.83%-7.82M	8.17%-36.85M
Investing cash flow
Cash flow from continuing investing activities	-265.90%-29.56M	65.09%-14.89M	-164.48%-12.28M	-7.14%35.53M	-66.88%-37.92M	-106.28%-8.08M	14.75%-42.66M	-60.21%19.04M	-55.50%38.27M	-150.68%-22.72M
Net PPE purchase and sale	-828.57%-130K	-233.33%-56K	50.00%-16K	-41.67%-34K	---24K	96.63%-14K	116.73%42K	37.25%-32K	59.32%-24K	--0
Net intangibles purchase and sale	--0	----	----	----	----	--0	----	----	----	----
Net investment purchase and sale	-264.92%-29.43M	65.25%-14.84M	-164.29%-12.26M	-7.11%35.57M	-66.77%-37.9M	-105.41%-8.06M	14.24%-42.7M	-60.18%19.07M	-55.50%38.29M	-135.02%-22.72M
Cash from discontinued investing activities
Investing cash flow	-265.90%-29.56M	65.09%-14.89M	-164.48%-12.28M	-7.14%35.53M	-66.88%-37.92M	-106.28%-8.08M	14.75%-42.66M	-60.21%19.04M	-55.50%38.27M	-150.68%-22.72M
Financing cash flow
Cash flow from continuing financing activities	-40.58%1.5M	-41.60%695K	52.91%552K	-70.85%158K	-78.72%90K	-57.25%2.52M	-1.82%1.19M	-86.53%361K	-38.90%542K	-61.75%423K
Net common stock issuance	-144.84%-2.21M	-162.00%-262K	-431.25%-1.11M	-1,645.83%-419K	26.19%-420K	---901K	97.86%-100K	-104.45%-208K	---24K	---569K
Proceeds from stock option exercised by employees	8.31%3.7M	-25.81%957K	191.21%1.66M	1.94%577K	-48.59%510K	-41.94%3.42M	--1.29M	--569K	-36.19%566K	-10.31%992K
Cash from discontinued financing activities
Financing cash flow	-40.58%1.5M	-41.60%695K	52.91%552K	-70.85%158K	-78.72%90K	-57.25%2.52M	-1.82%1.19M	-86.53%361K	-38.90%542K	-61.75%423K
Net cash flow
Beginning cash position	0.20%122.72M	-32.96%117.83M	19.36%112.57M	27.31%80.62M	0.20%122.72M	7.20%122.47M	-7.58%175.76M	-43.92%94.31M	-47.26%63.32M	7.20%122.47M
Current changes in cash	-6,124.90%-14.76M	81.39%-9.87M	-93.54%5.26M	3.12%31.95M	28.83%-42.1M	-97.02%245K	21.66%-53.05M	269.91%81.45M	-35.58%30.98M	-1,116.60%-59.15M
End cash Position	-12.03%107.95M	-12.03%107.95M	-32.96%117.83M	19.36%112.57M	27.31%80.62M	0.20%122.72M	0.20%122.72M	-7.58%175.76M	-43.92%94.31M	-47.26%63.32M
Free cash flow	130.99%13.17M	136.98%4.27M	-72.64%16.97M	52.42%-3.78M	88.35%-4.29M	103.89%5.7M	39.67%-11.54M	317.20%62.03M	79.56%-7.94M	38.77%-36.85M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall